About
Precision BioSciences develops genome-editing technologies based on its proprietary ARCUS nuclease platform to enable targeted DNA modifications for therapeutic cell therapies and gene editing treatments targeting rare genetic diseases and other conditions.
Explore Precision BioSciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.